| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/2008 | CN100361674C Chinese medicine extract with function of reducing blood-sugar and preparing method |
| 01/16/2008 | CN100361672C Red sage root ligustrazine freeze dried injecta and preparation method thereof |
| 01/16/2008 | CN100361666C Kudzu vine capsule for regulating blood pressure and blood fat, its preparation process |
| 01/16/2008 | CN100361665C Compositions and methods for treatment of mitochondrial diseases |
| 01/16/2008 | CN100361664C Pharmaceutical formulations |
| 01/16/2008 | CN100361663C Gel containing phytosterol and its preparing method |
| 01/16/2008 | CN100361662C Preparation method of traditional Chinese medicine compositions formulation |
| 01/16/2008 | CN100361661C Stable eye lotion containing latanoprost as active ingredient |
| 01/16/2008 | CN100361660C Levofloxacin slow release micropill, its preparation method and uses |
| 01/16/2008 | CN100361659C Composite vitamin B powdery injection for venous infusion and preparation thereof |
| 01/16/2008 | CN100361658C In situ-forming eye gel composition of ganciclovir and preparation method thereof |
| 01/16/2008 | CN100361657C Fluorouracial nano particle formulation and its preparing method |
| 01/16/2008 | CN100361656C Butylbenzene phthalein self emulsifying releasing medicine system, preparation method and application |
| 01/16/2008 | CN100361655C (-)-epigallocatechin gallate-calcium complex solid dispersion and its prepn and application |
| 01/16/2008 | CN100361654C Body-building weight-reducing capsule and its preparation process |
| 01/16/2008 | CN100361653C Tiopronin soft capsule |
| 01/16/2008 | CN100361652C Gel type dexketoprofen plaster and method for preparing the same |
| 01/16/2008 | CN100361651C Intravenous nanoparticles for targenting drug delivery and sustained drug release |
| 01/16/2008 | CN100361646C Use of olive oil in preparation of products for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in mouth |
| 01/16/2008 | CN100361644C Hair growth stimulant compositions |
| 01/16/2008 | CN100361584C Broad-spectrum antiseptics and production thereof |
| 01/15/2008 | US7319170 Hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes; N-[(cyclohexylamino)carbonyl]-4-{3-[4-(4-fluorophenoxy)-2-propylphenoxy]propoxy}benzenesulfonamide |
| 01/15/2008 | US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 01/15/2008 | US7319160 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 01/15/2008 | US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 01/15/2008 | US7319148 Comprising reactive hydrazide function used as initial synthons for preparing compounds capable of inducing mutations or capable of inhibiting a DNA polymerase or a kinase |
| 01/15/2008 | US7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists |
| 01/15/2008 | US7319110 1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity |
| 01/15/2008 | US7319109 4-(Substituted phenoxy or anilino)-3-phenyl- or phenylalkylisoxazoles: 3-{[(4-{[3-(2,6-Dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}-2-methylphenyl)-(methyl)amino]methyl}benzoic acid; cardiovascular disease, cholestatic liver disease, organ fibrosis, triglycerides, increasing high density lipoprotein |
| 01/15/2008 | US7319108 Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
| 01/15/2008 | US7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 01/15/2008 | US7319106 such as (cis)-6-(3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane; for controlling synaptic transmission, neurotransmitter release |
| 01/15/2008 | US7319105 Cytotoxic agents |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319103 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders |
| 01/15/2008 | US7319102 Pyrrolo[2,3-d]pyrimidine cytokine inhibitors |
| 01/15/2008 | US7319101 catechol-O-methyltransferase (COMT) inhibitors such as N-{3-[5-(6-Amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-yl]-allyl}-2,3-dihydroxy-benzamide used for the treatment of schizophrenia, Parkinson's disease and as antidepressants or cognition activators |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | US7319099 Benzoyl-piperazine derivatives |
| 01/15/2008 | US7319098 1,3-dioxoisoindole derivatives having selective antagonism of T-type calcium channel |
| 01/15/2008 | US7319097 Treatment of type II diabetes with benzenesulfonamide substituted with an N-heterocycle: N-[2-amino-5-(1,4-diazepan-1-yl)phenyl]benzenesulfonamide, N-[4-amino-5-(piperazinyl)phenyl]benzenesulfonamide, 3-amino-4-(5-methyl-2,5-diaza-bicyclo[2.2.1]hept-2-yl)-N-phenyl-benzenesulfonamide hydrochloride |
| 01/15/2008 | US7319096 Antiarrhythmia agents; liver disorders; skin disorders |
| 01/15/2008 | US7319095 Administering an optionally substituted 3-aminopropylphosphinic acid or 3-aminopropylsulfinic acid; chronic cough |
| 01/15/2008 | US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition |
| 01/15/2008 | US7319093 Antidiabetic 2-substituted-5′-O-(1-Boranotriphosphate) adenosine derivatives |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | US7319090 Methods of treating cerebral ischemia |
| 01/15/2008 | US7318938 Plant extract; cognition activators |
| 01/15/2008 | US7318936 Minimization of drug oxidation in drug irradiated excipients formulations |
| 01/15/2008 | US7318934 Method for treating wounds to promote healing |
| 01/15/2008 | US7318907 Apparatus for use in the detection of preferential particles in sample |
| 01/15/2008 | CA2536914C Crystal forms of azithromycin |
| 01/15/2008 | CA2432225C Sustained release drug delivery devices with prefabricated permeable plugs |
| 01/15/2008 | CA2419934C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 01/15/2008 | CA2400567C Tamper-resistant oral opioid agonist formulations |
| 01/15/2008 | CA2394155C Process for producing methylcobalamin |
| 01/15/2008 | CA2388835C Method for treating gastrointestinal disorders |
| 01/15/2008 | CA2335514C Alkyl ether analogs of chlorins having an n-substituted imide ring |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2312839C Compositions for nasal administration |
| 01/15/2008 | CA2307776C Capsular preparation containing unsaturated fatty acid or derivative thereof and process for producing the same |
| 01/15/2008 | CA2303195C Optically active 1,4-benzodioxine-2-carboxylic acid derivatives and process for producing the same |
| 01/15/2008 | CA2290331C Phytosterol and/or phytostanol derivatives |
| 01/15/2008 | CA2272971C Quinone derivatives for treating or preventing diseases associated with iron overload |
| 01/15/2008 | CA2265666C Cytostatic hydroxamic acid derivatives |
| 01/15/2008 | CA2253130C A medicament for treating obesity and improving lipid metabolism |
| 01/15/2008 | CA2251966C Transdermally administered dextromethorphan as antitussive agent |
| 01/15/2008 | CA2251744C Methods for identifying predisposition to osteoarthritis by a vitamin d receptor genotype |
| 01/15/2008 | CA2251087C Injection formulations of avermectins and milbemycins based on castor oil |
| 01/15/2008 | CA2244389C Cilansetron pharmaceutical preparation stabilized against racemization |
| 01/15/2008 | CA2225724C Pharmaceutical combined preparation, kit and method for hormonal contraception |
| 01/15/2008 | CA2221496C Production scale method of forming microparticles |
| 01/15/2008 | CA2218479C 1,4-di-substituted piperidine derivatives |
| 01/15/2008 | CA2216887C Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases |
| 01/15/2008 | CA2210684C Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 01/15/2008 | CA2205874C Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 01/15/2008 | CA2152563C Non-reducing saccharide and its production and use |
| 01/15/2008 | CA2145527C Tissue protective and regenerative compositions |
| 01/15/2008 | CA2123405C Angiostatic steroids |
| 01/15/2008 | CA2054762C Production of enzymes in seeds and their use |
| 01/11/2008 | CA2552493A1 Methods for producing interfering rnas |
| 01/11/2008 | CA2551982A1 Derivatives of n-[(1,5-diphenyl-1h-pyrazol-3-yl)methyl]sulphonamide,their preparation and their application in therapeutics |
| 01/10/2008 | WO2008006118A2 Novel regimens for treating diseases and disorders |
| 01/10/2008 | WO2008006117A2 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
| 01/10/2008 | WO2008006113A2 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 01/10/2008 | WO2008006106A2 Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
| 01/10/2008 | WO2008006099A2 Treatment of psychiatric disorders |
| 01/10/2008 | WO2008006093A2 Estrogen receptor modulators and uses thereof |
| 01/10/2008 | WO2008006085A2 Compositions and methods for predicting inhibitors of protein targets |
| 01/10/2008 | WO2008006070A2 Compounds and combinations thereof for inhibiting beta-amyloid production and methods of use thereof |
| 01/10/2008 | WO2008006064A2 Biomimetic polymers and uses thereof |
| 01/10/2008 | WO2008006058A2 Alkyl lactyllactate solvent compositions |
| 01/10/2008 | WO2008006052A2 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | WO2008006051A2 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | WO2008006050A2 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | WO2008006046A1 Ceramide composition and use thereof in treatment of ocular diseases |
| 01/10/2008 | WO2008006044A2 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/10/2008 | WO2008006043A2 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents |